Bayesian Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.37M |
| 2 |
Micron Technology
MU
|
+$5.24M |
| 3 |
PayPal
PYPL
|
+$5.12M |
| 4 |
Boeing
BA
|
+$4.77M |
| 5 |
Johnson & Johnson
JNJ
|
+$4.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$14.9M |
| 2 |
Apple
AAPL
|
+$11.5M |
| 3 |
TSMC
TSM
|
+$7.38M |
| 4 |
AbbVie
ABBV
|
+$7.33M |
| 5 |
Alibaba
BABA
|
+$5.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.29% |
| 2 | Healthcare | 13.97% |
| 3 | Consumer Discretionary | 13.78% |
| 4 | Industrials | 11.12% |
| 5 | Miscellaneous | 9.8% |
Similar funds
Bayesian Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Bayesian Capital Management held 733 positions worth $383M, down 6.5% from $409M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bayesian Capital Management withdrew a net $70.7M in Q4 2020, closing 302 positions and reducing 105 holdings. Its most notable exit was Microsoft, an estimated $14.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Bayesian Capital Management opened a new position in Micron Technology worth $6.53M.
- Bayesian Capital Management's largest Q4 2020 buy was Micron Technology: 86,900 shares worth $6.53M.
- Bayesian Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $9.37M increase.
- Bayesian Capital Management's biggest Q4 2020 reduction was Zoom, cutting an estimated $5.12M.
- Bayesian Capital Management fully exited Microsoft in Q4 2020, selling an estimated $14.9M.
- Bayesian Capital Management's ten largest holdings make up 18% of its $383M portfolio in Q4 2020.
- Bayesian Capital Management opened 236 new positions and closed 302 in Q4 2020.
- Bayesian Capital Management's portfolio value fell 6.5% quarter-over-quarter to $383M.
Based on Bayesian Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.